CD40LG and irritable bowel syndrome: Previous studies on graft versus host disease [146], IBD/IBS [147], and HIV disease [148], which all involved an increase in lipopolysaccharide secretion soluble CD14 (LPS-sCD14) and EndoCAb-IgM, have described MT as an exclusive pathogenic feature.